SARSCoV2

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection News-Medical.NetCovid-19 of ‘natural origin’ or ‘lab leak’? A tale of two theories The Indian ExpressHuman antibodies found that can block multiple…

81% of international flights into NYC had SARS-CoV-2 in waste, small trial finds Ars TechnicaNotes from the Field: Aircraft Wastewater Surveillance for Early Detection of SARS-CoV-2 Variants — John F. Kennedy International Airport, New…

To the Editor: In recent months, omicron (B.1.1.529) became the dominant variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), displaying some degree of immune evasion.1 The initial omicron subvariants, BA.1 and BA.2,…

On April 1, 2022, this report was posted online as an MMWR Early Release.Jason P. Block, MD1; Tegan K. Boehmer, PhD2; Christopher B. Forrest, MD, PhD3; Thomas W. Carton, PhD4; Grace M. Lee, MD5; Umed A. Ajani, MBBS2; Dimitri A.…

On March 18, 2022, this report was posted online as an MMWR Early Release.Christopher A. Taylor, PhD1; Michael Whitaker, MPH1; Onika Anglin, MPH1,2; Jennifer Milucky, MSPH1; Kadam Patel, MPH1,2; Huong Pham, MPH1; Shua J. Chai, MD3,4;…

On February 25, 2022, this report was posted online as an MMWR Early Release.Julia M. Baker, PhD1,2,*; Jasmine Y. Nakayama, PhD1,2,*; Michelle O’Hegarty, PhD1; Andrea McGowan, MPH1,3; Richard A. Teran, PhD2,4; Stephen M. Bart, PhD2,5;…

On February 1, 2022, this report was posted online as an MMWR Early Release.Summary What is already known about this topic? COVID-19 vaccines are highly effective against severe SARS-CoV-2–associated outcomes, including those caused by…

To the Editor: Across the world, there are multiple variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19). SARS-CoV-2 variants have been classified by the…